BMO Capital Markets expressed confidence in Gilead Sciences (NASDAQ:GILD), with analyst Evan David Seigerman increasing the company's price target to $115 from the previous $110, while maintaining an ...

That's generally thought to be a genuine positive, so investors may expect to see an increasing share price. The image below shows how EPS has tracked over time (if you click on the image you can ...

I rate Willdan a Strong Buy, expecting a 25% price increase over the next year due ... Willdan’s financial fortunes are rising while its share price declines. And, I take a contrarian position ...

That's generally thought to be a genuine positive, so investors may expect to see an increasing share price. Given that the company made a profit three years ago, but not five years ago ...

The report late on Thursday found that Starboard has amassed a 7.7% position in the company and is seeking changes to boost the company's lagging share price, according to people familiar with the ...